Solange Peters Honored with the IASLC Paul A. Bunn, Jr. Scientific Award 2025

The International Association for the Study of Lung Cancer (IASLC), a global organization dedicated to eradicating thoracic malignancies, has announced its 2025 Distinguished Service Award recipients. Among the four exceptional honorees, Solange Peters, MD, PhD, has been awarded the distinguished Paul A. Bunn, Jr. Scientific Award, recognizing her lifetime achievement in thoracic cancer research.

About the Paul A. Bunn, Jr. Scientific Award

The Paul A. Bunn, Jr. Scientific Award honors IASLC scientists for their lifetime contributions to thoracic cancer research. The award is named after Dr. Paul Bunn, whose pioneering studies established global standards for lung cancer treatment and advanced understanding of disease progression, prognosis, and therapy selection through biomarkers.

The first recipient, Robert Ginsberg, MD, a thoracic surgeon from Toronto, Canada, was recognized in 1994 for his groundbreaking work in the surgical management of early-stage lung cancer. Originally called the Scientific Award, it was later renamed in Dr. Bunn’s honor following his 10-year tenure as IASLC executive director and CEO, reflecting his profound impact on the field.

Solange Peters: A Trailblazer in Thoracic Oncology

Prof. Solange Peters is the Oncology Director at Lausanne University Hospital and leads the thoracic malignancies program. She holds both a Doctorate in Medicine and a PhD from the University Hospital of Lausanne and trained in medical oncology and molecular biology in Switzerland and Italy. She specializes in thoracic tumors, lung cancer, and pleural tumors.

Her research focuses on novel biomarker discovery, multimodality strategies for locally advanced non-small cell lung cancer (NSCLC), and cancer immunotherapy. She serves as local principal investigator for lung trials at Lausanne Cancer Centre and co-PI for several other trials. Prof. Peters holds multiple leadership roles: she chairs the European Thoracic Oncology Platform (ETOP) scientific committee, presides over the Swiss Academy of Multidisciplinary Oncology (SAMO), and is Vice Director of the Swiss National Cancer League. She was also the youngest-ever President of the European Society for Medical Oncology (ESMO) and founded the Women for Oncology Committee to promote gender equity.

Academic and Editorial Contributions

A prolific scholar, Prof. Peters has authored over 500 peer-reviewed manuscripts and book chapters. She is Associate Editor of the Annals of Oncology, Deputy Editor of Lung Cancer, and serves on several other oncology journal editorial boards.

She was Deputy Editor of the Journal of Thoracic Oncology for 10 years. Prof. Peters is deeply involved in education, creating the Women for Oncology Committee within the European Society for Medical Oncology (ESMO). She also contributed as a member of the IASLC Board of Directors.

Celebrating Solange Peters: Social Media Congratulations

Following the announcement of Dr. Solange Peters’ IASLC Paul A. Bunn, Jr. Scientific Award 2025, the oncology and research communities have shared their congratulations on social media. The original congratulatory post was made by Stephen V. Liu, which has since been reposted and shared several times across X/Twitter, reflecting the respect Dr. Peters commands in the field of thoracic oncology.

“Huge congratulations to Dr. Solange Peters – the recipient of the International Association for the Study of Lung Cancer 2025 Paul A. Bunn Scoentific Award. No one more deserving. A force who continues to make a huge impact on all.”

Dr. Amy C. Moore reposted the above-mentioned post, adding:

“Congratulations, Dr. Solange Peters! Very well deserved!”

Hidehito Horinouchi also congratulated, writing:

“Congratulations Solange Peters. Paul A. Bunn, Jr. Scientific Award”

Celebrating a Lifetime of Impact

Receiving the Paul A. Bunn, Jr. Scientific Award highlights Prof. Peters’ exceptional contributions to lung cancer research and patient care. Her work continues to inspire and guide the next generation of oncology leaders worldwide.

Moreover, she is highly active on X/Twitter and LinkedIn, sharing her expertise in medical oncology, particularly in thoracic malignancies and cancer immunotherapy. Her posts provide invaluable insights into biomarker discovery, NSCLC treatment strategies, and innovative cancer therapies. Follow Dr. Peters on X/Twitter and LinkedIn to stay updated on her groundbreaking research and contributions to advancing oncology.

You can read more articles featuring Solange Peters on Oncodaily’s website.

Written by Sergey Badalyan, MD